| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/05/2001 | EP1158960A1 Modified carrier particles for use in dry powder inhalers |
| 12/05/2001 | EP1158959A1 Compositions and methods for improved delivery of hydrophobic therapeutic agents |
| 12/05/2001 | EP1158958A1 Improved powdery pharmaceutical compositions for inhalation |
| 12/05/2001 | EP1158957A1 Liquid suppository composition of diclofenac sodium |
| 12/05/2001 | EP1142903A9 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb 1? |
| 12/05/2001 | EP1067904B1 Solid, quick dissolving cetirizine formulations |
| 12/05/2001 | EP1063983B1 Transdermal therapeutic system (tts) containing oxybutynin |
| 12/05/2001 | EP1051158B1 Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization |
| 12/05/2001 | EP1026947B1 Composition and method for treating penile erectile dysfunction |
| 12/05/2001 | EP1019039B1 Compressed nitroglycerin tablet and its method of manufacture |
| 12/05/2001 | EP0996424B1 Solid pharmaceutical preparation |
| 12/05/2001 | EP0994693B1 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 12/05/2001 | EP0971880B1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid |
| 12/05/2001 | EP0955999B1 Novel liposome complexes for increased systemic delivery |
| 12/05/2001 | EP0941094B1 Process for manufacturing ophthalmic suspensions containing brinzolamide |
| 12/05/2001 | EP0904282B1 Novel cationic cholesteryl derivatives containing cyclic polar groups |
| 12/05/2001 | EP0868187B1 Transdermal estradiol/progestogen agent patch and its production |
| 12/05/2001 | EP0862414B1 Ophthalmic compositions containing cyclodextrins and quaternary ammonium compounds |
| 12/05/2001 | EP0859596B1 Gel formulations containing growth factors |
| 12/05/2001 | EP0814841B1 Hcg liquid formulations |
| 12/05/2001 | EP0814815A4 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 12/05/2001 | EP0814800B1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 12/05/2001 | EP0792142B1 Fusogenic liposomes |
| 12/05/2001 | EP0786985B1 Method and composition for treatment of abnormal conditions of the epithelium of bodily orifices |
| 12/05/2001 | EP0783341B1 Improved transdermal device having decreased delamination |
| 12/05/2001 | EP0754032B1 Liquid delivery compositions |
| 12/05/2001 | EP0721337B1 Oral formulations of an antifungal |
| 12/05/2001 | EP0721331B1 Process i |
| 12/05/2001 | EP0706377B1 Sustained release excipient |
| 12/05/2001 | EP0697867B1 Compositions in the form of solid solutions |
| 12/05/2001 | EP0692972B1 Method for delivering beneficial compositions to hair follicles |
| 12/05/2001 | EP0445255B2 USE OF HYALURONIC ACID IN COMBINATION WITH ASCORBIC ACID, ANTITUMOUR AGENTS AND/OR NSAIDs FOR TREATING CANCER |
| 12/05/2001 | CN2462966Y Umbilicus therapeutic patch for treatment of diarrhea |
| 12/05/2001 | CN2462923Y Hydrogel cosmetic skin-care patch |
| 12/05/2001 | CN1325534A Apparatus and method for brachytherapy |
| 12/05/2001 | CN1325387A 2,4-disubstituted triazine derivatives |
| 12/05/2001 | CN1325315A Implant with cavities containing therapeutic agents |
| 12/05/2001 | CN1325312A Muco-adhesive polymers, use thereof and method for producing the same |
| 12/05/2001 | CN1325310A Remedies for bone metabolic errors |
| 12/05/2001 | CN1325306A Pharmaceutical moxifloxacin preparation |
| 12/05/2001 | CN1325305A Method of administering camptothecin compounds for the treatment of cancer with reduced side effects |
| 12/05/2001 | CN1325302A Use of dialkylfumarates |
| 12/05/2001 | CN1325301A Controlled delivery of active agents |
| 12/05/2001 | CN1325300A Pharmaceutical formulation comprising omeprazole |
| 12/05/2001 | CN1325299A Orally administered controlled drug delivery system providing temporal and spatial control |
| 12/05/2001 | CN1325298A Method for producing solid dosing forms |
| 12/05/2001 | CN1325286A Manganese compositions and methods for MRI |
| 12/05/2001 | CN1325271A Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 12/05/2001 | CN1325270A Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the N-hydroxy anilide-type |
| 12/05/2001 | CN1325266A Disposable premoistened wipe containing an antimicrobial protease inhibitor |
| 12/05/2001 | CN1324659A Vagina spry containing biological active factor |
| 12/05/2001 | CN1324658A Vagina spray with repair function |
| 12/05/2001 | CN1324655A Ointment for treating burns and scalds and its prepn. |
| 12/05/2001 | CN1324627A Diabetes treating medicine and its prepn. method |
| 12/05/2001 | CN1324622A Bone-strengthening and pus-drawing out ointment |
| 12/05/2001 | CN1324613A Use of taxiol stabilized by albumin in preparing emdicine for treating body tumor and medicine obtained therefrom |
| 12/05/2001 | CN1324611A Eye medicine prepn. for computer eyesight syndrome and xerophthalmia |
| 12/05/2001 | CN1324607A Anti-fungus agent for local treatment of fungus infection of finger and its peripheral tissue and controllable releasable system of keratin-dissolving agnt |
| 12/05/2001 | CN1075737C Method for the provocation of air passage narrowing and/or the induction of sputum |
| 12/05/2001 | CN1075734C Medicine for treating hyperosteogeny |
| 12/05/2001 | CN1075733C Face-nourishing oral liquor and its preparation method |
| 12/05/2001 | CN1075731C Medicine for treating nasal polyp |
| 12/05/2001 | CN1075730C Wind-dispelling meridian passage-dredging and pus-drawing out medicinal powder |
| 12/05/2001 | CN1075727C Capsule for treating nervous lesion and production method thereof |
| 12/05/2001 | CN1075726C Oral liquid for treatment of heart disease |
| 12/05/2001 | CN1075725C Medicine for curing thrombocytopenic purpura and anemia |
| 12/05/2001 | CN1075724C Suppository for curing prostatosis |
| 12/05/2001 | CN1075722C Fungicidal compositions containing bifonazole |
| 12/04/2001 | US6327426 Apparatus and method for delivering a beneficial agent |
| 12/04/2001 | US6326406 Heating aqueous solution containing lecithin and bile acid salt |
| 12/04/2001 | US6326401 Formulation for the oromucosal, in particular pernasal, route |
| 12/04/2001 | US6326389 Administering sodium channel modulators |
| 12/04/2001 | US6326384 Dry blend pharmaceutical unit dosage form |
| 12/04/2001 | US6326360 Bubbling enteric coated preparations |
| 12/04/2001 | US6326353 123therapy for septic shock; administering polymyxin by injection |
| 12/04/2001 | US6326195 Recombinant retroviral vector |
| 12/04/2001 | US6326028 Alginate and gellan gum as tablet coating |
| 12/04/2001 | US6326027 Solid, oral dosage form, comprising tramadol or its salt in matrix providing at least twelve hour effectiveness |
| 12/04/2001 | US6326026 Caplet core containing a drug with peripheral edge surface that is bowed in shape; caplet coated with a gelatinous material; optional subcoating of a polymer, e.g. hydroxypropyl methyl cellulose |
| 12/04/2001 | US6326023 Synergistic anti-malarial formulation |
| 12/04/2001 | US6326021 Mixing glycolic acid-lactic acid copolymer with surface-active polymer solutions to provide emulsion; evaporating solvent to form polymeric matrix |
| 12/04/2001 | US6326020 As a nerve blocking agent, sodium channel blocker in combination with vasoconstrictors, adrenergic drugs, vanilloids, amphi-philic, or lipophilic solvents, glucocorticoids; prolonged or modality selective |
| 12/04/2001 | US6326017 Applying polymer matrix impregnated with treatment drug directly to artery or vein and covering with a barrier to restrict the release of drug to the surface of the artery or vein to produce localized effect |
| 12/04/2001 | US6326002 Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract |
| 12/04/2001 | US6325993 Oral adhesive sheet and oral adhesive preparation |
| 12/04/2001 | US6325991 Methods and compositions for treating periodontal disease with an inhibitor of secretory phospholipase A2 |
| 12/04/2001 | US6325990 Film forming composition for spraying on the skin |
| 12/04/2001 | CA2231440C Wet wipes with low viscosity silicone emulsion systems |
| 12/04/2001 | CA2197941C A pharmaceutical tablet characterized by a showing high volume increase when coming into contact with biological fluids |
| 12/04/2001 | CA2196840C Pharmaceutical tablet suitable to deliver the active substance in subsequent and predeterminable times |
| 12/04/2001 | CA2195014C Positive photoactive compounds based on 2,6-dinitrobenzyl groups |
| 12/04/2001 | CA2152186C Lyophilized emulsion containing an active substance |
| 12/04/2001 | CA2085884C Pressurized hydrofluorocarbon aerosol compositions |
| 12/04/2001 | CA2040914C Treatment of erectile dysfunction |
| 11/29/2001 | WO2001090226A1 Cross-linked polymeric nanoparticles and metal nanoparticles derived therefrom |
| 11/29/2001 | WO2001090144A2 Vip-related peptides for the treatment of sexual disorders in women |
| 11/29/2001 | WO2001090057A1 Sulfonamide derivatives |
| 11/29/2001 | WO2001089816A1 Crystalline polymeric compositions for ophthalmic devices |
| 11/29/2001 | WO2001089679A2 Continuous production of pharmaceutical granulates |
| 11/29/2001 | WO2001089616A1 Aerosol container for formulations of salmeterol xinafoate |